期刊文献+

SALL4基因在宫颈癌组织中的表达及意义 被引量:3

Expression and clinical significance of SALL4 gene in cervical cancer
原文传递
导出
摘要 目的探讨SALL4基因在宫颈癌组织中的表达及意义。方法收集31例宫颈癌组织和17例正常宫颈组织,用RT-PCR检测SALL4mRNA的表达,用Western blot在蛋白水平上进行验证。分析SALL4在宫颈癌中的表达水平与临床病理因素的相关性。结果宫颈癌组织中SALL4表达高于正常宫颈组织(P<0.01);Western blot在蛋白水平上证实了这一点。宫颈癌组织中SALL4的表达与肿瘤分化状态密切相关(P<0.05),与年龄、FIGO分期、肿瘤大小、病理类型和淋巴结是否转移无明显关系。结论宫颈癌组织中SALL4mRNA的表达上调,且与宫颈癌的分化相关。SALL4的基因和蛋白水平检测可能成为宫颈癌诊断和预后监测的新指标。 Objective To investigate the expression and clinical significance of SALL4 gene in cervical cancer tissues. Methods The primary tumor tissues from 31 cervical cancer patients and 17 normal cervical tissues were collected. The expression of SALL4 was detected by RT-PCR. SALL4 protein levels were confirmed by Western blot. The correlation analysis was conducted to assess the relationship between SALL4 expression and clinical pathological parameters. Results The results of RT-PCR showed that the expression rate of SALL4 gene in the cervical cancer tissues was significantly higher than that in normal cervical tissues (P〈0. 01 ), which was verified by the expression of SALL4 protein levels detected by Western blot. SALL4 expression in the cervical cancer tissues was closely related with the differentiation status of tumor(P〈0. 05), but not with age, FIGO stage, tumor size, pathological type and lymph node metastasis. Conclusion SALL4 expression in the cervical cancer tissues is upregulated, which is closely associated with the differentiation status and may be a novel marker for diagnosing and assessing the prognosis of cervical cancer.
出处 《江苏医药》 CAS 北大核心 2014年第4期441-443,共3页 Jiangsu Medical Journal
基金 常州市科技计划指导性项目(CY20120018) 常州市卫生局指导性科技项目(WZ201120)
关键词 SALL4基因 宫颈癌 SALL4 gene Cervical cancer
  • 相关文献

参考文献1

二级参考文献139

  • 1Bernards R. Cancer: cues for migration. Nature 2003; 425:247-248.
  • 2Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6:459-469.
  • 3Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308.
  • 4John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7:14-23.
  • 5Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2:826-835.
  • 6Pratap J, Javed A, Languino LR, et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol2005; 25:8581-8591.
  • 7Chinni SR, Sivalogan S, Dong Z, et al. CXCL 12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.Prostate 2006; 66:32-48.
  • 8Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109:625-637.
  • 9Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ, Cabuhat ML. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol 2000; 28:1274-1285.
  • 10Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003; 112:160-169.

共引文献85

同被引文献45

  • 1张建平,谢幸,吕卫国.趋化因子与肿瘤的定向转移[J].国外医学(肿瘤学分册),2005,32(5):351-354. 被引量:8
  • 2Lindquist D, Kvarnbrink S, Henriksson R, et al. LRIG and cancer prognosis [ J ]. Acta Oneol, 2014,53 (9) ." 1135 - 1142.
  • 3Goetsch L,Caussanel V,Corvaia N. Biological significance and targeting of c-Met tyrosine kinase receptor in cancer [J]. Front Biosci (Landmark Ed), 2013(18) :454-473.
  • 4Mug, hal A,Aslam HM,Sheikh A,et al. c-Met inhibitors [J]. Infect Agent Cancer, 2013,8 ( 1 ) : 13.
  • 5Comuno?lu C, Boynukalin K, U~ur MG, et al. Overexpression of c- Met in cervical intraepithelial neoplasiaE J ]. Eur J Gynaecol Oncol, 2012,33(6):625-628.
  • 6Leo C, Horn LC, Einenkel J, et al. Tumor hypoxia and expression of c-met in cervical cancer [ J ]. Gynecol Oncol, 2007,104 ( 1 ) : 181- 185.
  • 7Ong CH, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell derived growth factor,acrogranin) in proliferation and tumorigenesis~J 1. Histol Histopathol,2003,18(4) : 1275-1288.
  • 8Bateman A, Bennett HP. The granulin gene family : from cancer to dementia[ J ]. Bioessays, 2009,31 ( 11 ) : 1245 - 1254.
  • 9De Muynck L,van Damme P. Cellular effects of progranuliu in health and disease[ J ]. J Mol Neurosci, 2011,45 (3) :549-560.
  • 10Lu Y,Zheng L,Zhang W,et al. Growth factor progranulin contributes to cervical cancer cell proliferation proliferation and transformation in vivo and in vitro [J]. Gynecol Oncol,2014,134 (2):364-371.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部